From: Computational fluid dynamics study of intra-arterial chemotherapy for oral cancer
Artery | Class 1 | Class 2 | Class 3 | Class 4 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C | LA (F) | LA (L) | LA (R) | LA (B) | C | LA (F) | LA (L) | LA (R) | LA (B) | C | LA (F) | LA (L) | LA (R) | LA (B) | ||
OA (L) | OA (B) | OA (F) | OA (R) | OA (L) | OA (B) | OA (F) | OA (R) | OA (L) | OA (B) | OA (F) | OA (R) | |||||
FA (B) | FA (R) | FA (L) | FA (F) | FA (B) | FA (R) | FA (L) | FA (F) | FA (B) | FA (R) | FA (L) | FA (F) | |||||
ICA | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
SThA | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
LA | 7.5 (56.8%) | 13.2 (100%) | 13.2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 13.2 (100%) |
OA | 0 (0%) | 0 (0%) | 0 (0%) | 5.6 (42.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2.5 (18.9%) | 0.1 (0.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
FA | 1.6 (12.1%) | 0 (0%) | 0 (0%) | 7.3 (55.3%) | 12.1 (91.7%) | 7.0 (53.0%) | 1.8 (13.6%) | 5.9 (44.7%) | 8.6 (65.2%) | 11.2 (84.8%) | 9.6 (72.7%) | 1.6 (12. 1%) | 12.8 (97.0%) | 13.1 (99.2%) | 13.0 (98.5%) | 0 (0%) |
PAA | 0.3 (2.3%) | 0 (0%) | 0 (0%) | 0.2 (1.5%) | 0 (0%) | 0.1 (0.8%) | 0 (0%) | 0 (0%) | 0.1 (0.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
MA | 0.3 (2.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 0.4 (3.0%) | 0.8 (6.1%) | 0.4 (3.0%) | 1.7 (12.9%) | 0.3 (2.3%) | 0.7 (5.3%) | 0.8 (6.1%) | 1.2 (9.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
MMA | 3.5 (26.5%) | 0 (0%) | 0 (0%) | 0.2 (1.5%) | 0.8 (6.1%) | 5.3 (40.2%) | 11.0 (83.3%) | 5.7 (43.2%) | 1.7 (12.9%) | 1.4 (10.6%) | 2.8 (21.2%) | 10.5 (79.5%) | 0.4 (3.0%) | 0.1 (0.8%) | 0.2 (1.5%) | 0 (0%) |